Jefferies Financial Group’s Organogenesis Holdings ORGO Stock Holding History

Jefferies Financial Group’s Portfolio ORGO Stock Details ORGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$233K	Buy	+170,000	New	+$334K	﹤0.01%	1113

Other funds holding ORGO

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Squarepoint New York $90.8B AUM 26.98% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return

Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

Wealth Dimensions Group Cincinnati, Ohio $590M AUM 14.89% 1-Year Est. Return

Jefferies Financial Group's ORGO Position: Q3 2026 in Review

Jefferies Financial Group opened a new position in Organogenesis Holdings (ORGO) in Q3 2026: 170,000 shares worth $233K. The stake represents ﹤0.01% of the portfolio and ranks #1113 among its holdings.

45 funds tracked by Wall St. Rank hold ORGO as of Q3 2026.

Jefferies Financial Group held 170,000 shares of Organogenesis Holdings worth $233K as of Q3 2026.
Organogenesis Holdings was a new Jefferies Financial Group position in Q3 2026.
Organogenesis Holdings made up ﹤0.01% of Jefferies Financial Group's portfolio in Q3 2026, its #1113 holding.
45 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q3 2026.

Based on Jefferies Financial Group's 13F filing for Q3 2026, filed 5 Nov 2026.